← The Journal

The mechanism · 4 min read

The quiet road from High Blood Pressure to a Heart Attack

The quiet road from high blood pressure to a heart attack Nothing hurts. Nothing shows. Then one day something blocks. Here is what is happening in your arteries between the first high reading and the event, and why the lining of the vessel is where it is decided.

The quiet road from High Blood Pressure to a Heart Attack

High blood pressure is called the silent killer because it does its work without symptoms for years. What it is doing in those years is not mysterious. Cardiologists have mapped it in detail. It is a story about a single layer of cells.

The gatekeeper

Every artery is lined with a layer one cell thick, the endothelium. It is not just a lining. It makes nitric oxide, keeps the vessel relaxed, stops platelets sticking and keeps inflammation out of the wall. When it is healthy, blood flows and nothing attaches. When it is damaged, the wall is open for business.1

Endothelial dysfunction can be detected before anything else is wrong. In children and young adults with risk factors for atherosclerosis, the arteries already relax less well than they should, decades before disease.2 It is the earliest measurable step, and a marker of what is to come.3

How pressure damages it

High pressure is a mechanical injury. It stretches the wall and roughens the lining, especially where arteries branch and flow is turbulent. Damaged endothelium makes less nitric oxide and lets more through. LDL cholesterol enters the wall, where it oxidises. The immune system responds to the oxidised LDL as it would to an invader, sending in cells that engulf it and become foam cells. A fatty streak forms, then a plaque.4


Atherosclerosis, in other words, is an inflammatory disease. The cholesterol is the fuel; the inflammation in a damaged wall is the fire.1 4

    A heart attack is rarely a vessel slowly closing. It is a plaque splitting open and a clot forming on the wound.

    The event

    Over years the plaque grows and the wall around it weakens and inflames. The dangerous plaques are not always the biggest; they are the ones with a thin cap and an inflamed core. When the cap ruptures, the blood meets the material inside and does what blood does to a wound: it clots. If the clot blocks a coronary artery, the muscle beyond it loses its supply. That is a heart attack.5 The same failure in an artery supplying the brain is a stroke.

    Where it is decided

    Follow the chain backwards and every step passes through the endothelium: the nitric oxide it stopped making, the inflammation it let in, the plaque it couldn't prevent, the rupture of a wall it no longer protected. Dr Caldwell Esselstyn, the Cleveland Clinic physician whose work on arresting and reversing heart disease is cited throughout this field, puts the whole chain in one sentence: “CAD [coronary artery disease] begins with progressive endothelial injury, inflammatory oxidative stress, diminution of nitric oxide production, foam cell formation, and development of plaques that may rupture to cause a myocardial infarction (MI) or stroke.”6 The same paper is as clear about the other direction. His patients were taught “the importance of the endothelial cell and its product, nitric oxide”, and when the foods that injure the lining are avoided, “the body readily restores the capacity of endothelial tissue to produce nitric oxide.”6 Strengthen the lining and you change the whole chain.

    What strengthens it

    Everything that raises nitric oxide and lowers inflammation in the wall: movement, nitrate-rich food, sleep, slow breathing, less smoke, less alcohol, less stress, antioxidants that let nitric oxide survive, and the minerals the wall runs on. Everything, that is, in the seven levers and the four pathways. Keep taking any medication you have been prescribed; it protects you while the lining recovers. And measure, so you can see it happening.

    References

    1. Bode-Böger SM, Böger RH, Galland A, Tsikas D, Frölich JC. L-arginine-induced vasodilation in healthy humans: pharmacokinetic–pharmacodynamic relationship. British Journal of Clinical Pharmacology 1998;46(5):489–497.
    2. Tangphao O, Grossmann M, Chalon S, Hoffman BB, Blaschke TF. Pharmacokinetics of intravenous and oral L-arginine in normal volunteers. British Journal of Clinical Pharmacology 1999;47(3):261–266.
    3. Castillo L, Chapman TE, Yu YM, Ajami A, Burke JF, Young VR. Dietary arginine uptake by the splanchnic region in adult humans. American Journal of Physiology 1993;265(4):E532–E539.
    4. Grimble GK. Adverse gastrointestinal effects of arginine and related amino acids. Journal of Nutrition 2007;137(6 Suppl 2):1693S–1701S.
    5. Curis E, Nicolis I, Moinard C, et al. Almost all about citrulline in mammals. Amino Acids 2005;29(3):177–205.
    6. Schwedhelm E, Maas R, Freese R, et al. Pharmacokinetic and pharmacodynamic properties of oral L-citrulline and L-arginine: impact on nitric oxide metabolism. British Journal of Clinical Pharmacology 2008;65(1):51–59.
    7. Moinard C, Nicolis I, Neveux N, Darquy S, Bénazeth S, Cynober L. Dose-ranging effects of citrulline administration on plasma amino acids and hormonal patterns in healthy subjects. British Journal of Nutrition 2008;99(4):855–862.
    8. Barkhidarian B, Khorshidi M, Shab-Bidar S, Hashemi B. Effects of L-citrulline supplementation on blood pressure: a systematic review and meta-analysis. Avicenna Journal of Phytomedicine 2019;9(1):10–20.
    9. Ochiai M, Hayashi T, Morita M, et al. Short-term effects of L-citrulline supplementation on arterial stiffness in middle-aged men. International Journal of Cardiology 2012;155(2):257–261.

    Study findings describe the cited trials at the doses shown; they are not a promise about your results. Nothing in the Journal is individual medical advice. If you take medication, keep taking it and talk to your physician.*

    Protect the lining.

    The Program and the community are included with every order. Alongside your physician, never instead.